Review




Structured Review

BioResource International Inc grade/stage tissue microarray (tma) slides
Grade/Stage Tissue Microarray (Tma) Slides, supplied by BioResource International Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prostate+tissue+microarray+slides/tissue+microarray/ppr0377422-47-7-29
Average 90 stars, based on 1 article reviews
grade/stage tissue microarray (tma) slides - by Bioz Stars, 2026-09
90/100 stars

Images

Related Articles

other:

Article Title: Expression and Subcellular Localization of Discoidin Domain Receptor 1 (DDR1) Define Prostate Cancer Aggressiveness
Article Snippet: Materials And Methods Prostate Tissue Specimens The Grade/Stage tissue microarray (TMA) slides containing de-identi ed human PCa specimens were obtained from the Prostate Cancer Biorepository Network (PCBN), a public bioresource for PCa investigators funded by the Department of Defense resulting from a collaboration between Johns Hopkins University and New York University School of Medicine (Provider Investigator: Dr. Bruce Trock, Johns Hopkins University, Baltimore, MD).

Article Title: Investigation of hormone receptor expression and its prognostic value in endometrial stromal sarcoma.
Article Snippet: To evaluate the immunohistochemical (IHC) expression of hormone receptors and analyze the prognostic implication of these receptors in patients with endometrial stromal sarcoma (ESS).. Fifty-one patients with ESS whose paraffin blocks and pathologic slides, which were obtained after hysterectomy, were available and included in this study.. Clinicopathologic data were gathered from patients’medical records, and IHC staining of hormone receptors was performed using tissue microarrays.

Article Title: ETS1 induces transforming growth factor β signaling and promotes epithelial-to-mesenchymal transition in prostate cancer cells.
Article Snippet: Anatomical Pathology, PathWest Laboratory Medicine, Royal Perth Hospital, Perth, Western Australia, Australia* School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia Anatomical Pathology, PathWest Laboratory Medicine, Fiona Stanley Hospital, Murdoch, Western Australia, Australia Laboratory for Cancer Medicine, Harry Perkins Institute of Medical Research, Nedlands, Western Australia, Australia Uropath, West Leederville, Western Australia, Australia Centre for Medical Research and Medical School, University of Western Australia, Crawley, Western Australia, Australia Anatomical Pathology, PathWest Laboratory Medicine, QEII Medical Centre, Crawley, Western Australia, Australia Australian Prostate Cancer BioResource (APCB), Brisbane, Queensland, Australia

Article Title: Temporary treatment cessation compared with continuation of tyrosine kinase inhibitors for adults with renal cancer: the STAR non-inferiority RCT
Article Snippet: The samples were collected by the NRS Lothian Bioresource in Edinburgh for future research from constructed STAR tissue micro-arrays (TMAs).

Microarray:

Article Title: MesobanK UK: an international mesothelioma bioresource
Article Snippet: MesobanK has been created to establish a bioresource of pleural mesothelioma tissue linked to detailed anonymised clinical data. .. When complete, the bioresource will comprise a 750-patient tissue microarray and prospectively collected tissue, blood and pleural fluid from 300 patients with mesothelioma. ..

Article Title: Location of CD39 + T cell subpopulations within tumors predict differential outcomes in non-small cell lung cancer.
Article Snippet: Tumor/non- cancerous lungNCL tissue and blood samples were obtained following approval by National Health Service (NHS) Lothian REC and facilitated by NHS Lothian SAHSC Bioresource (REC No: 15/ ES/0094), with informed consent from all patients. .. The tissue microarray (TMA) was approved NHS Lothian REC and facilitated by NHS Lothian SAHSC Bioresource (REC No: 15/ES/0094) and approved by delegated authority granted to R&D by the NHS Lothian Caldicott Guardian (Application number CRD19031). ..

Article Title: A Novel Approach for the Discovery of Biomarkers of Radiotherapy Response in Breast Cancer
Article Snippet: .. Ethical approval for use of tissue microarray samples from the Breast-Conserving Series was granted under the Lothian NRS BioResource approval number 20/ES/0061. ..

Article Title: Cancer-associated fibroblasts expressing fibroblast activation protein and podoplanin in non-small cell lung cancer predict poor clinical outcome
Article Snippet: .. The tissue microarray was approved NHS Lothian REC and facilitated by NHS Lothian SAHSC Bioresource (REC No: 15/ES/0094) and approved by delegated authority granted to R&D by the NHS Lothian Caldicott Guardian (Application number CRD19031). ..



Similar Products

90
Biomax Inc human prostate tissue microarray slides
Human Prostate Tissue Microarray Slides, supplied by Biomax Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prostate+tissue+microarray+slides/human+prostate+tissue+microarray+slides/pm37491794-82-0-8
Average 90 stars, based on 1 article reviews
human prostate tissue microarray slides - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

91
U.S Biomax Inc prostate cancer tissue microarray slides
Examination of Prx4 protein levels in patient specimens of prostate cancer by tissue <t>microarray</t> or established prostate cancer cell lines by Western blotting. A , tissue microarray slides and representative images of anti-Prx4 staining of prostate normal and adenocarcinoma. Positive anti-Prx4 staining shows in dark brown and counter staining for nuclear shows light blue . The scale bars represent 5 mm (whole slide), 500 μm (individual tumor), and 100 μm (zoomed in). B and C , anti-Prx4 staining intensity were quantitatively scored by board-certified pathologist and data were compared between prostate normal (n = 50) and adenocarcinoma (n = 66) ( B ), as well as between prostate normal and cancer with different levels of Gleason grading ( C ). D , examination of Prx4 levels in prostate derived nontumorigenic or tumor cell lines by Western blotting. The bar graph on the right shows quantitative data from three independent blots. ∗ p < 0.05 by two-way ANOVA. Prx, peroxiredoxin.
Prostate Cancer Tissue Microarray Slides, supplied by U.S Biomax Inc, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prostate+tissue+microarray+slides/Normal+prostate+tissue+array%2C+24+cases%2F+48+cores/pmc09257407-276-4-16
Average 91 stars, based on 1 article reviews
prostate cancer tissue microarray slides - by Bioz Stars, 2026-09
91/100 stars
  Buy from Supplier

90
U.S Biomax Inc human prostate tissue microarray slides
Examination of Prx4 protein levels in patient specimens of prostate cancer by tissue <t>microarray</t> or established prostate cancer cell lines by Western blotting. A , tissue microarray slides and representative images of anti-Prx4 staining of prostate normal and adenocarcinoma. Positive anti-Prx4 staining shows in dark brown and counter staining for nuclear shows light blue . The scale bars represent 5 mm (whole slide), 500 μm (individual tumor), and 100 μm (zoomed in). B and C , anti-Prx4 staining intensity were quantitatively scored by board-certified pathologist and data were compared between prostate normal (n = 50) and adenocarcinoma (n = 66) ( B ), as well as between prostate normal and cancer with different levels of Gleason grading ( C ). D , examination of Prx4 levels in prostate derived nontumorigenic or tumor cell lines by Western blotting. The bar graph on the right shows quantitative data from three independent blots. ∗ p < 0.05 by two-way ANOVA. Prx, peroxiredoxin.
Human Prostate Tissue Microarray Slides, supplied by U.S Biomax Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prostate+tissue+microarray+slides/Human+Prostate+Cancer/pm33564069-245-8-15
Average 90 stars, based on 1 article reviews
human prostate tissue microarray slides - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

86
Thermo Fisher immunofluorescence microscopy maxarray prostate cancer bph tissue microarray slides
Examination of Prx4 protein levels in patient specimens of prostate cancer by tissue <t>microarray</t> or established prostate cancer cell lines by Western blotting. A , tissue microarray slides and representative images of anti-Prx4 staining of prostate normal and adenocarcinoma. Positive anti-Prx4 staining shows in dark brown and counter staining for nuclear shows light blue . The scale bars represent 5 mm (whole slide), 500 μm (individual tumor), and 100 μm (zoomed in). B and C , anti-Prx4 staining intensity were quantitatively scored by board-certified pathologist and data were compared between prostate normal (n = 50) and adenocarcinoma (n = 66) ( B ), as well as between prostate normal and cancer with different levels of Gleason grading ( C ). D , examination of Prx4 levels in prostate derived nontumorigenic or tumor cell lines by Western blotting. The bar graph on the right shows quantitative data from three independent blots. ∗ p < 0.05 by two-way ANOVA. Prx, peroxiredoxin.
Immunofluorescence Microscopy Maxarray Prostate Cancer Bph Tissue Microarray Slides, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prostate+tissue+microarray+slides/us10094836-722-7-17
Average 86 stars, based on 1 article reviews
immunofluorescence microscopy maxarray prostate cancer bph tissue microarray slides - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

90
Aperio Technologies prostate cancer tissue microarray slides
a Quantitation of gene expression in microdissected prostate stroma by <t>microarray</t> hybridization before (Pre) and after (Post) exposure to mitoxantrone and docetaxel (≥1.5-fold increase with p<0.05). Expanded heatmap shows a subset of the transcripts encoding extracellular proteins.
Prostate Cancer Tissue Microarray Slides, supplied by Aperio Technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prostate+tissue+microarray+slides/prostate+cancer+tissue+microarray+slides/pmc05859576-57-0-11
Average 90 stars, based on 1 article reviews
prostate cancer tissue microarray slides - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Biomax Inc human prostate tissue microarray (tma) slides pr483b
a Quantitation of gene expression in microdissected prostate stroma by <t>microarray</t> hybridization before (Pre) and after (Post) exposure to mitoxantrone and docetaxel (≥1.5-fold increase with p<0.05). Expanded heatmap shows a subset of the transcripts encoding extracellular proteins.
Human Prostate Tissue Microarray (Tma) Slides Pr483b, supplied by Biomax Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prostate+tissue+microarray+slides/human+prostate+tissue+microarray++tma++slides+pr483b/pm27869166-158-0-9
Average 90 stars, based on 1 article reviews
human prostate tissue microarray (tma) slides pr483b - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
U.S Biomax Inc prostate normal cancer tissue microarray slides
CatL expression increases with tumor progression. (A) Immunohistochemical (IHC) analysis was performed using a 96 core prostate adenocarcinoma tissue <t>microarray.</t> Representive images of CatL in various stages of prostate cancer show that CatL increases with tumor progression. Bar represents 50 µM. (B) Normal/tumor matched invasive ductal carcinoma (IDC) grades 1 and 3, infiltrating carcinoma (IFC) grade 3, adenocarcinoma (grade 3) and metaplastic carcinoma (MPC) grade 3 were analyzed for expression of CatL by western blot analysis. Mature CatL expression was generally higher in tumor as compared to normal tissue. Alpha (α)-tubulin was used as a loading control. Data are representative of at least three independent experiments.
Prostate Normal Cancer Tissue Microarray Slides, supplied by U.S Biomax Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prostate+tissue+microarray+slides/Prostate+cancer+tissue+array+with+unmatched+normal+prostate+tissues%2C+24+cases%2F48+cores%2C+with+grades%2C+stages+and+Gleason+scores/pmc04643647-90-22-28
Average 90 stars, based on 1 article reviews
prostate normal cancer tissue microarray slides - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


Examination of Prx4 protein levels in patient specimens of prostate cancer by tissue microarray or established prostate cancer cell lines by Western blotting. A , tissue microarray slides and representative images of anti-Prx4 staining of prostate normal and adenocarcinoma. Positive anti-Prx4 staining shows in dark brown and counter staining for nuclear shows light blue . The scale bars represent 5 mm (whole slide), 500 μm (individual tumor), and 100 μm (zoomed in). B and C , anti-Prx4 staining intensity were quantitatively scored by board-certified pathologist and data were compared between prostate normal (n = 50) and adenocarcinoma (n = 66) ( B ), as well as between prostate normal and cancer with different levels of Gleason grading ( C ). D , examination of Prx4 levels in prostate derived nontumorigenic or tumor cell lines by Western blotting. The bar graph on the right shows quantitative data from three independent blots. ∗ p < 0.05 by two-way ANOVA. Prx, peroxiredoxin.

Journal: The Journal of Biological Chemistry

Article Title: Peroxiredoxin IV plays a critical role in cancer cell growth and radioresistance through the activation of the Akt/GSK3 signaling pathways

doi: 10.1016/j.jbc.2022.102123

Figure Lengend Snippet: Examination of Prx4 protein levels in patient specimens of prostate cancer by tissue microarray or established prostate cancer cell lines by Western blotting. A , tissue microarray slides and representative images of anti-Prx4 staining of prostate normal and adenocarcinoma. Positive anti-Prx4 staining shows in dark brown and counter staining for nuclear shows light blue . The scale bars represent 5 mm (whole slide), 500 μm (individual tumor), and 100 μm (zoomed in). B and C , anti-Prx4 staining intensity were quantitatively scored by board-certified pathologist and data were compared between prostate normal (n = 50) and adenocarcinoma (n = 66) ( B ), as well as between prostate normal and cancer with different levels of Gleason grading ( C ). D , examination of Prx4 levels in prostate derived nontumorigenic or tumor cell lines by Western blotting. The bar graph on the right shows quantitative data from three independent blots. ∗ p < 0.05 by two-way ANOVA. Prx, peroxiredoxin.

Article Snippet: Human prostate normal and prostate cancer tissue microarray slides were commercially obtained, including BNS19011 and PR803d (US Biomax).

Techniques: Microarray, Western Blot, Staining, Derivative Assay

a Quantitation of gene expression in microdissected prostate stroma by microarray hybridization before (Pre) and after (Post) exposure to mitoxantrone and docetaxel (≥1.5-fold increase with p<0.05). Expanded heatmap shows a subset of the transcripts encoding extracellular proteins.

Journal: Molecular cancer research : MCR

Article Title: DNA Damage Induces a Secretory Program in the Quiescent TME that Fosters Adverse Cancer Phenotypes

doi: 10.1158/1541-7786.MCR-16-0387

Figure Lengend Snippet: a Quantitation of gene expression in microdissected prostate stroma by microarray hybridization before (Pre) and after (Post) exposure to mitoxantrone and docetaxel (≥1.5-fold increase with p<0.05). Expanded heatmap shows a subset of the transcripts encoding extracellular proteins.

Article Snippet: Prostate cancer tissue microarray slides were scanned on Aperio ScanScope AT (Aperio Technologies, Vista, CA, USA).

Techniques: Quantitation Assay, Gene Expression, Microarray, Hybridization

CatL expression increases with tumor progression. (A) Immunohistochemical (IHC) analysis was performed using a 96 core prostate adenocarcinoma tissue microarray. Representive images of CatL in various stages of prostate cancer show that CatL increases with tumor progression. Bar represents 50 µM. (B) Normal/tumor matched invasive ductal carcinoma (IDC) grades 1 and 3, infiltrating carcinoma (IFC) grade 3, adenocarcinoma (grade 3) and metaplastic carcinoma (MPC) grade 3 were analyzed for expression of CatL by western blot analysis. Mature CatL expression was generally higher in tumor as compared to normal tissue. Alpha (α)-tubulin was used as a loading control. Data are representative of at least three independent experiments.

Journal: Carcinogenesis

Article Title: Muscadine grape skin extract can antagonize Snail-cathepsin L-mediated invasion, migration and osteoclastogenesis in prostate and breast cancer cells

doi: 10.1093/carcin/bgv084

Figure Lengend Snippet: CatL expression increases with tumor progression. (A) Immunohistochemical (IHC) analysis was performed using a 96 core prostate adenocarcinoma tissue microarray. Representive images of CatL in various stages of prostate cancer show that CatL increases with tumor progression. Bar represents 50 µM. (B) Normal/tumor matched invasive ductal carcinoma (IDC) grades 1 and 3, infiltrating carcinoma (IFC) grade 3, adenocarcinoma (grade 3) and metaplastic carcinoma (MPC) grade 3 were analyzed for expression of CatL by western blot analysis. Mature CatL expression was generally higher in tumor as compared to normal tissue. Alpha (α)-tubulin was used as a loading control. Data are representative of at least three independent experiments.

Article Snippet: Immunohistochemistry Examination of the expression and distribution of CatL in human prostate cancer was performed by immunohistochemistry (IHC) using prostate normal and cancer tissue microarray slides obtained from US Biomax (PR956a, Rockville, MD).

Techniques: Expressing, Immunohistochemical staining, Microarray, Western Blot